Barbados vs Oman: Cause of death, by non-communicable diseases, ages 5-14, female
Barbados
45.8%
in 2021
Oman
45.6%
in 2021
Barbados rank
73rd
Oman rank
74th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Barbados
- Oman
How they compare
Barbados currently reports 45.8% against 45.6% in Oman, a difference of 0.2%.
Across all 6 years both countries report, Barbados has been ahead every year.
Barbados ranks 73rd and Oman ranks 74th of 184 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.8% | 42.0% | 6.8% | Barbados |
| 2010s | 48.0% | 44.6% | 3.4% | Barbados |
| 2020s | 48.2% | 48.0% | 0.1% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Barbados or Oman?
- Barbados, at 45.8% against 45.6% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Barbados and Oman?
- 0.2%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Oman?
- 6 years are reported by both, from 2000 to 2021.
- How do Barbados and Oman rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Barbados ranks 73rd and Oman ranks 74th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.